Emily Herman is a 33-year-old wife and mother of two children. She and her family reside in Minneapolis, Minnesota.
At age 19, she started to experience dizziness and shortness of breath during physical activity. Eventually, Herman was diagnosed with hypertrophic cardiomyopathy, a condition that puts her at increased risk of sudden cardiac arrest. She has been managing her condition for over 13 years and has an implanted cardioverter defibrillator (ICD). The ICD continuously monitors her heart for abnormal rhythms and sends an electrical impulse to prevent sudden cardiac death, if needed.
Kenneth Stein, M.D., F.A.C.C.
Senior Vice President and Chief Medical Officer,
Cardiac Rhythm Management Division
Ken Stein, M.D., F.A.C.C., is Senior Vice President and Chief Medical Officer of Cardiac Rhythm Management and Global Health Policy for Boston Scientific. In this role, he oversees the development and execution of CRM’s clinical strategy.
Prior to joining Boston Scientific in 2009, Dr. Stein was Associate Director of Clinical Cardiac Electrophysiology at Weill Cornell Medical Center and Associate Professor of Medicine at Cornell University.
He earned a M.D. from New York University School of Medicine. Dr. Stein completed his medical internship and residency at The New York-Presbyterian Hospital/Weill Cornell Medical Center where he also completed his cardiology and electrophysiology training. He earned a B.A. in Economics (Magna Cum Laude) from Harvard College, where he finished as a Phi Beta Kappa graduate.
Dr. Stein has published widely in the areas of cardiac electrophysiology with a special interest in cardiac resynchronization therapy and risk stratification for sudden cardiac arrest.